Profile
Bob Deresiewicz is currently a Director at Asher Biotherapeutics, Inc. Previously, he was a Senior Managing Director and Partner at Wellington Management Co. LLP (Private Equity) from 2000 to 2022.
He obtained an undergraduate degree from The Trustees of Columbia University in The City of New York, a doctorate from Icahn School of Medicine at Mount Sinai, and an MBA from Harvard Business School.
Bob Deresiewicz active positions
| Companies | Position | Start |
|---|---|---|
Asher Biotherapeutics, Inc.
Asher Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunotherapies | Director/Board Member | 06/07/2022 |
Former positions of Bob Deresiewicz
| Companies | Position | End |
|---|---|---|
Wellington Management Co. LLP (Private Equity)
Wellington Management Co. LLP (Private Equity) Investment ManagersFinance Wellington Management invests in companies located in the US. The firm targets companies in sectors such as consumer, technology, healthcare, financial services, climate technology and biotechnology. It provides financing for later stage capital requirements. | Private Equity Investor | 30/06/2022 |
Training of Bob Deresiewicz
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 5 |
|---|---|
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wellington Management Co. LLP (Private Equity)
Wellington Management Co. LLP (Private Equity) Investment ManagersFinance Wellington Management invests in companies located in the US. The firm targets companies in sectors such as consumer, technology, healthcare, financial services, climate technology and biotechnology. It provides financing for later stage capital requirements. | Finance |
Asher Biotherapeutics, Inc.
Asher Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunotherapies | Health Technology |
- Stock Market
- Insiders
- Bob Deresiewicz
















